Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation
Open Access
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 25 (3) , 480-487
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases (4U10HL069294)
- Health Resources and Services Administration (N0014-17-1-2850, N00014-17-1-2388)
- Public Health Service (5U24CA076518)
This publication has 14 references indexed in Scilit:
- Impact of Dose-Adjusted Melphalan in Obese Patients Undergoing Autologous Stem Cell TransplantationTransplantation and Cellular Therapy, 2018
- BEAM conditioning is well-tolerated and yields similar survival in obese and non-obese patients with lymphoma: no requirement for weight-based dose modificationsBone Marrow Transplantation, 2017
- Adjusting Cyclophosphamide Dose in Obese Patients with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2016
- Effect of Obesity on Outcomes after Autologous Hematopoietic Stem Cell Transplantation for Multiple MyelomaTransplantation and Cellular Therapy, 2011
- Implications of Obesity for Drug Therapy: Limitations and ChallengesClinical Pharmacology & Therapeutics, 2011
- Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphomaBritish Journal of Haematology, 2008
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTBlood, 2005
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005
- The Origin of the “Ideal” Body Weight EquationsAnnals of Pharmacotherapy, 2000
- Score test of homogeneity for survival dataLifetime Data Analysis, 1995